Cliff Asness's ORIC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 358,751 shares of ORIC Pharmaceuticals, Inc. (ORIC) worth $3.89 M, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ORIC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 188,664 shares. Largest reduction occurred in Q3 2022, reducing 12,508 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ORIC Pharmaceuticals (ORIC) Holding Value Over Time
Track share changes against reported price movement
Quarterly ORIC Pharmaceuticals (ORIC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +188,664 | Add 110.92% | 358,751 | $10.83 |
| Q1 2026 | -4,192 | Reduce 2.41% | 170,087 | $12.67 |
| Q4 2025 | +2,354 | Add 1.37% | 174,279 | $8.18 |
| Q3 2025 | +492 | Add 0.29% | 171,925 | $12.00 |
| Q2 2025 | +121,903 | Add 246.12% | 171,433 | $10.15 |
| Q1 2025 | +49,530 | New Buy | 49,530 | $5.58 |
| Q3 2024 | -12,241 | Sold Out | 0 | $0.00 |
| Q2 2024 | -2,057 | Reduce 14.39% | 12,241 | $7.07 |
| Q1 2024 | +152 | Add 1.07% | 14,298 | $13.75 |
| Q4 2023 | +2,947 | Add 26.31% | 14,146 | $9.20 |
| Q3 2023 | +11,199 | New Buy | 11,199 | $6.05 |
| Q3 2022 | -12,508 | Sold Out | 0 | $0.00 |
| Q2 2022 | +12,508 | New Buy | 12,508 | $4.48 |
Cliff Asness's ORIC Pharmaceuticals Investment FAQs
Cliff Asness first purchased ORIC Pharmaceuticals, Inc. (ORIC) in Q2 2022, acquiring 12,508 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ORIC Pharmaceuticals, Inc. (ORIC) for 13 quarters since Q2 2022.
Cliff Asness's largest addition to ORIC Pharmaceuticals, Inc. (ORIC) was in Q2 2026, adding 358,751 shares worth $3.89 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 358,751 shares of ORIC Pharmaceuticals, Inc. (ORIC), valued at approximately $3.89 M.
As of the Q2 2026 filing, ORIC Pharmaceuticals, Inc. (ORIC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ORIC Pharmaceuticals, Inc. (ORIC) was 358,751 shares, as reported at the end of Q2 2026.